abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2007년 9월 24일

저자:
Nopporn Wong-Anan, Reuters

Thailand may override patents on some cancer drugs

Thailand, which has overridden international patents on three drugs in the past year, plans to issue four more licences for copycat versions of cancer medicines, Health Ministry officials said...The government would impose compulsory licences on four drugs sold by Novartis…Sanofi-Aventis …and Roche…if negotiations with the global pharmaceutical giants to lower prices failed, they said...[refers also to Abbott Laboratories and Merck]